Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,355 | -11,902 | -7,889 | -3,964 | -11,501 |
| Depreciation Amortization | 180 | 144 | 99 | 53 | 213 |
| Other Working Capital | 8,461 | 177 | -452 | -877 | 562 |
| Other Operating Activity | 1,873 | 1,593 | 1,092 | 597 | 126 |
| Operating Cash Flow | $-15,842 | $-9,987 | $-7,150 | $-4,192 | $-10,601 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -37 | -19 | -8 | -88 |
| Purchase Of Investment | -2,072 | -2,072 | -1,570 | -305 | -14,446 |
| Sale Of Investment | 10,835 | 10,835 | 9,754 | 3,971 | 7,178 |
| Other Investing Activity | 43 | 42 | 40 | 25 | -67 |
| Investing Cash Flow | $8,766 | $8,768 | $8,205 | $3,682 | $-7,424 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,000 | 2,000 | N/A | N/A | N/A |
| Common Stock Issued | 7 | 5 | 3 | 2 | 18,831 |
| Dividend Paid | N/A | N/A | N/A | N/A | -315 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -65 |
| Financing Cash Flow | $8,007 | $2,005 | $3 | $2 | $18,450 |
| Beginning Cash Position | 579 | 579 | 579 | 579 | 153 |
| End Cash Position | 1,509 | 1,364 | 1,637 | 70 | 579 |
| Net Cash Flow | $930 | $785 | $1,058 | $-508 | $426 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,842 | -9,987 | -7,150 | -4,192 | -10,601 |
| Capital Expenditure | -40 | -37 | -19 | -8 | -88 |
| Free Cash Flow | -15,882 | -10,025 | -7,169 | -4,200 | -10,689 |